Literature DB >> 10375632

Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue.

X Wu1, H H Gu.   

Abstract

Drug abuse is a serious problem in the United States and in the world. Cocaine and amphetamines, widely used drugs of abuse, bind to dopamine (DA), serotonin, and norepinephrine transporters with high affinity and block their functions. It is believed that the dopamine transporter plays a key role in the mechanism of cocaine addiction. Because a good portion of our knowledge about drug addiction is derived from studying mouse as an animal model, it is essential to compare the properties of dopamine transporter from human and mouse. We report here the cloning of the mouse dopamine transporter (mDAT) cDNA and its expression and comparison with the human DAT. The 3.4 kilobase (kb) cDNA encodes a polypeptide that is 93.5% identical to the hDAT, with 619 amino acid residues and a calculated molecular weight of 68.8kDa. Dopamine transporters from mouse and human were stably expressed in the same parental MDCK cells and their properties were compared. The Michaelis-Menten constant Km values are 2.0 microM for mDAT and 2.4 microM for hDAT. Mouse and human DAT were also compared for drug inhibition profiles. Dopamine transporters from the two species have the same sensitivity to amphetamine (Kd: 0.75 microM) and bupropion (Kd: 1.5 microM). However, hDAT is more sensitive than mDAT to cocaine (Kd: 0.14 microM and 0. 29 microM respectively) and to ritalin (Kd: 0.038 microM and 0. 12 microM respectively). The cloning of mDAT cDNA provides an important tool for further study of the mechanism of drug addiction using mouse as an animal model.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375632     DOI: 10.1016/s0378-1119(99)00143-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  Dopamine release and uptake dynamics within nonhuman primate striatum in vitro.

Authors:  S J Cragg; C J Hille; S A Greenfield
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription.

Authors:  B Liss; O Franz; S Sewing; R Bruns; H Neuhoff; J Roeper
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

3.  Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.

Authors:  Dilip K Tosh; Aaron Janowsky; Amy J Eshleman; Eugene Warnick; Zhan-Guo Gao; Zhoumou Chen; Elizabeth Gizewski; John A Auchampach; Daniela Salvemini; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2017-03-20       Impact factor: 7.446

4.  Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation.

Authors:  James D Foster; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

Review 5.  Model systems for analysis of dopamine transporter function and regulation.

Authors:  Moriah J Hovde; Garret H Larson; Roxanne A Vaughan; James D Foster
Journal:  Neurochem Int       Date:  2018-09-01       Impact factor: 3.921

6.  Methylphenidate enhances extinction of contextual fear.

Authors:  Antony D Abraham; Christopher L Cunningham; K Matthew Lattal
Journal:  Learn Mem       Date:  2012-01-17       Impact factor: 2.460

7.  Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic-pharmacodynamic modelling approach.

Authors:  T Lehr; A Staab; C Tillmann; E Ø Nielsen; D Trommeshauser; H G Schaefer; C Kloft
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

8.  Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.

Authors:  Ernesto Solis
Journal:  Curr Top Behav Neurosci       Date:  2017

9.  Polymorphism of the 3'-UTR of the dopamine transporter gene (DAT) in New World monkeys.

Authors:  Marco Lucarelli; Elisabetta Visalberghi; Walter Adriani; Elsa Addessi; Silvia Pierandrei; Arianna Manciocco; Francesca Zoratto; Andrea Tamellini; Augusto Vitale; Giovanni Laviola; Jessica Lynch Alfaro; Esterina Pascale
Journal:  Primates       Date:  2016-08-08       Impact factor: 2.163

10.  Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux.

Authors:  James D Foster; Jae-Won Yang; Amy E Moritz; Sathyavathi Challasivakanaka; Margaret A Smith; Marion Holy; Kyle Wilebski; Harald H Sitte; Roxanne A Vaughan
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.